Taher Entezari-Maleki

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Left Ventricular

Percutaneous Coronary Intervention

St Segment Elevation Myocardial Infarction

Top Venues

International journal of surgery (London, England)

Journal of clinical pharmacology

American journal of cardiovascular drugs : drugs, devices, and other interventions

Journal of cardiovascular and thoracic research

This page only lists publications with an associated author ORCID identifier.

Publications

Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Elnaz Khani, Naser Aslanabadi, Kazem Mehravani, Haleh Rezaei, Hoda Afsharirad, Taher Entezari-Maleki
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions 24 (5) (2024)
Hossein Behzad, Sina Mashayekhi, Hila Asham, Parvin Sarbakhsh, Taher Entezari-Maleki
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial. Journal of cardiovascular and thoracic research 16 (2) (2024)
Hossein Namdar, Elnaz Khani, Sajad Khiali, Naser Safaie, Hedieh Ameli, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial. Journal of cardiovascular and thoracic research 16 (1) (2024)
Hossein Behzad, Hila Asham, Samineh Beheshtirouy, Sina Mashayekhi, Negin Jafari, Taher Entezari-Maleki
Sodium-glucose cotransporter-2 inhibitors in individuals with ischemia reperfusion injury: A systematic review. Perfusion (2024)
Hossein Namdar, Elnaz Khani, Sajad Khiali, Naser Safaie, Hedieh Ameli, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effects of citalopram on blood pressure control in depressive patients with hypertension: A randomized clinical trial. Journal of cardiovascular and thoracic research 16 (1) (2024)
Fariba Pourkarim, Taher Entezari-Maleki
Clinical considerations on monkeypox antiviral medications: An overview. Pharmacology research & perspectives 12 (1) (2023)
Mohammadreza Taban-Sadeghi, Elnaz Khani, Kimia Khezripour, Elgar Enamzadeh, Naser Safaei, Taher Entezari-Maleki
Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial. Journal of clinical pharmacology (2023)
Bentelhoda Afsharirad, Taher Entezari-Maleki
Enoxaparin's potential mechanisms against SARS-CoV-2. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Bentelhoda Afsharirad, Taher Entezari-Maleki
Enoxaparin's potential mechanisms against SARS-CoV-2. International journal of surgery (London, England) 109 (1) (2023)
Bentelhoda Afsharirad, Taher Entezari-Maleki
Enoxaparin's potential mechanisms against SARS-CoV-2. International journal of surgery (London, England) 109 (1) (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Sajad Khiali, Amin Agabalazadeh, Hadi Sahrai, Hossein Bannazadeh Baghi, Gholamreza Rahbari Banaeian, Taher Entezari-Maleki
Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review. Pharmaceutical medicine (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Bentelhoda Afsharirad, Taher Entezari-Maleki
Enoxaparin's potential mechanisms against SARS-CoV-2. International journal of surgery (London, England) 109 (1) (2023)
Sajad Khiali, Mohammadreza Taban Sadeghi, Parvin Sarbakhsh, Naser Khezerlouy-Aghadam, Taher Entezari-Maleki
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial. European journal of clinical pharmacology (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Bentelhoda Afsharirad, Taher Entezari-Maleki
Enoxaparin's potential mechanisms against SARS-CoV-2. International journal of surgery (London, England) 109 (1) (2023)
Fariba Pourkarim, Taher Entezari-Maleki
Clinical considerations on monkeypox antiviral medications: An overview. Pharmacology research & perspectives 12 (1) (2023)
Sajad Khiali, Mohammadreza Taban Sadeghi, Parvin Sarbakhsh, Naser Khezerlouy-Aghadam, Taher Entezari-Maleki
Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial. European journal of clinical pharmacology (2023)
Elnaz Khani, Taher Entezari-Maleki
Commentary on 'Implications of the SARS-CoV-2 subvariants BA.4 and BA.5'. International journal of surgery (London, England) 109 (1) (2023)
Sajad Khiali, Afra Rezagholizadeh, Taher Entezari-Maleki
SARS-CoV-2 and probable lung cancer risk. BioImpacts : BI 12 (3) (2022)
Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic. Future microbiology 17 (2022)
Elnaz Khani, Taher Entezari-Maleki
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists. Molecular psychiatry 27 (9) (2022)
Samineh Beheshtirouy, Elnaz Khani, Sajad Khiali, Taher Entezari-Maleki
Investigational antiviral drugs for the treatment of COVID-19 patients. Archives of virology 167 (3) (2022)
Sajad Khiali, Taher Entezari-Maleki
New Variants of SARS-CoV-2 and Next Generation of COVID-19 Treatments. Journal of clinical pharmacology 62 (9) (2022)
Elnaz Khani, Bentelhoda Afsharirad, Taher Entezari-Maleki
Monkeypox treatment: Current evidence and future perspectives. Journal of medical virology (2022)
Elnaz Khani, Sajad Khiali, Taher Entezari-Maleki
Potential COVID-19 Therapeutic Agents and Vaccines: An Evidence-Based Review. Journal of clinical pharmacology 61 (4) (2021)
Sajad Khiali, Taher Entezari-Maleki
Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy. Journal of clinical pharmacology 61 (9) (2021)
Sajad Khiali, Elnaz Khani, Taher Entezari-Maleki
A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome. Journal of clinical pharmacology 60 (9) (2020)
Hossein Namdar, Elnaz Khani, Mohammad Hassan Pourrashid, Taher Entezari-Maleki
Effects of Adding Pentoxifylline to Captopril on Primary Hypertension: A Pilot Randomized Clinical Trial. Journal of clinical pharmacology 60 (2) (2019)
Naser Aslanabadi, Roghayeh Afsar Gharebagh, Saba Moharramzadeh, Taher Entezari-Maleki
Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial. International urology and nephrology 51 (4) (2019)
Sajad Khiali, Afshin Gharekhani, Taher Entezari-Maleki
Isotretinoin; A review on the Utilization Pattern in Pregnancy. Advanced pharmaceutical bulletin 8 (3) (2018)
Naser Aslanabadi, Iraj Jafaripor, Selda Sadeghi, Hadi Hamishehkar, Samad Ghaffari, Mehdi Toluey, Hanieh Azizi, Taher Entezari-Maleki
Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial. Journal of clinical pharmacology 58 (2) (2017)
Hossein Namdar, Rasoul Zohori, Naser Aslanabadi, Taher Entezari-Maleki
Effect of Pentoxifylline in Ameliorating Myocardial Injury in Patients With Myocardial Infarction Undergoing Thrombolytic Therapy: A Pilot Randomized Clinical Trial. Journal of clinical pharmacology 57 (10) (2017)